Literature DB >> 24525512

SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases.

Markku Miettinen1, Zengfeng Wang, Peter A McCue, Maarit Sarlomo-Rikala, Janusz Rys, Wojciech Biernat, Jerzy Lasota, Yi-Shan Lee.   

Abstract

The SALL4 transcription factor is associated with embryonic cell pluripotency and has been shown as a useful immunohistochemical marker for germ cell tumors. However, information of SALL4 distribution in normal human tissues and non-germ cell tumors is limited. In this study we examined normal human tissues and 3215 tumors for SALL4 expression using a monoclonal antibody 6E3 and automated immunohistochemistry. In a 10-week embryo, SALL4 was expressed in ovocytes, intestine, kidney, and some hepatocytes. In adult tissues, it was only detected in germ cells. SALL4 was consistently expressed in all germ cell tumors except some trophoblastic tumors and mature components of teratomas, in which it was selectively expressed in intestinal-like and some squamous epithelia. In non-germ cell carcinomas, SALL4 was detected in 20% of cases or more of serous carcinoma of the ovary, urothelial high-grade carcinoma, and gastric adenocarcinoma (especially the intestinal type). SALL4 was only rarely (≤ 5%) expressed in mammary, colorectal, prostatic, and squamous cell carcinomas. Many SALL4-positive carcinomas showed poorly differentiated patterns, and some showed positivity in most tumor cells mimicking the expression in germ cell tumors. SALL4 was commonly expressed in rhabdoid tumors of the kidney and extrarenal sites and in the Wilms tumor. Expression of SALL4 was rare in other mesenchymal and neuroendocrine tumors but was occasionally detected in melanoma, desmoplastic small round cell tumor, epithelioid sarcoma, and rhabdomyosarcoma. All hematopoietic tumors were negative. SALL4 is an excellent marker of nonteratomatous germ cell tumors, but it is also expressed in other tumors, sometimes extensively. Such expression may reflect stem cell-like differentiation and must be considered when using SALL4 as a marker for germ cell tumors. Observed lack of other pluripotency factors, OCT4 and NANOG, in SALL4-positive non-germ cell tumors can also be diagnostically helpful.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24525512      PMCID: PMC4041084          DOI: 10.1097/PAS.0000000000000116

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  28 in total

1.  SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer.

Authors:  Daisuke Kobayashi; Kageaki Kuribayshi; Maki Tanaka; Naoki Watanabe
Journal:  Int J Oncol       Date:  2011-01-27       Impact factor: 5.650

2.  Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells.

Authors:  Qiang Wu; Xi Chen; Jinqiu Zhang; Yuin-Han Loh; Teck-Yew Low; Weiwei Zhang; Wensheng Zhang; Siu-Kwan Sze; Bing Lim; Huck-Hui Ng
Journal:  J Biol Chem       Date:  2006-07-13       Impact factor: 5.157

3.  A gene regulatory network in mouse embryonic stem cells.

Authors:  Qing Zhou; Hiram Chipperfield; Douglas A Melton; Wing Hung Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-10       Impact factor: 11.205

4.  Overexpression of SALL4 in lung cancer and its importance in cell proliferation.

Authors:  Daisuke Kobayashi; Kageaki Kuribayashi; Maki Tanaka; Naoki Watanabe
Journal:  Oncol Rep       Date:  2011-07-01       Impact factor: 3.906

5.  Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1.

Authors:  Jinqiu Zhang; Wai-Leong Tam; Guo Qing Tong; Qiang Wu; Hsiao-Yun Chan; Boon-Seng Soh; Yuefei Lou; Jianchang Yang; Yupo Ma; Li Chai; Huck-Hui Ng; Thomas Lufkin; Paul Robson; Bing Lim
Journal:  Nat Cell Biol       Date:  2006-09-17       Impact factor: 28.824

6.  Immunoexpression of SALL4 in Wilms tumors and developing kidney.

Authors:  Jeremy Deisch; Jack Raisanen; Dinesh Rakheja
Journal:  Pathol Oncol Res       Date:  2011-01-22       Impact factor: 3.201

7.  α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.

Authors:  Hiroko Ikeda; Yasunori Sato; Norihide Yoneda; Kenichi Harada; Motoko Sasaki; Seiko Kitamura; Yoshiko Sudo; Akishi Ooi; Yasuni Nakanuma
Journal:  Hum Pathol       Date:  2012-04-17       Impact factor: 3.466

8.  SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.

Authors:  Dengfeng Cao; Shuangping Guo; Robert W Allan; Kyle H Molberg; Yan Peng
Journal:  Am J Surg Pathol       Date:  2009-06       Impact factor: 6.394

9.  Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.

Authors:  Fenghua Wang; Aijun Liu; Yan Peng; Dinesh Rakheja; Lixin Wei; Debin Xue; Debing Xue; Robert W Allan; Kyle H Molberg; Jianping Li; Dengfeng Cao
Journal:  Am J Surg Pathol       Date:  2009-10       Impact factor: 6.394

10.  SALL4 is a novel diagnostic marker for testicular germ cell tumors.

Authors:  Dengfeng Cao; Jianping Li; Charles C Guo; Robert W Allan; Peter A Humphrey
Journal:  Am J Surg Pathol       Date:  2009-07       Impact factor: 6.394

View more
  39 in total

1.  Teratoma of the Sellar Region: a Case Report.

Authors:  Wolfgang Saeger; Azadeh Ebrahimi; Rudi Beschorner; Hildegard Spital; Jürgen Honegger; Waldemar Wilczak
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

2.  Primary yolk sac tumour of the prostate mimicking small round blue cell tumour.

Authors:  H Gui; R A Kolster; M B Palmer; J S Brooks; M Zhang; M A Husson
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

3.  Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases.

Authors:  Aatur D Singhi; Raja R Seethala; Katie Nason; Tyler J Foxwell; Robyn L Roche; Kevin M McGrath; Ryan M Levy; James D Luketich; Jon M Davison
Journal:  Hum Pathol       Date:  2014-12-17       Impact factor: 3.466

4.  SALL4 promotes glycolysis and chromatin remodeling via modulating HP1α-Glut1 pathway.

Authors:  J Kim; S Xu; L Xiong; L Yu; X Fu; Y Xu
Journal:  Oncogene       Date:  2017-07-31       Impact factor: 9.867

5.  Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.

Authors:  Shingo Inaguma; Jerzy Lasota; Zengfeng Wang; Piotr Czapiewski; Renata Langfort; Janusz Rys; Joanna Szpor; Piotr Waloszczyk; Krzysztof Okoń; Wojciech Biernat; Hiroshi Ikeda; David S Schrump; Raffit Hassan; Markku Miettinen
Journal:  Hum Pathol       Date:  2017-08-12       Impact factor: 3.466

Review 6.  SALL4, the missing link between stem cells, development and cancer.

Authors:  Hiro Tatetsu; Nikki R Kong; Gao Chong; Giovanni Amabile; Daniel G Tenen; Li Chai
Journal:  Gene       Date:  2016-02-16       Impact factor: 3.688

Review 7.  Functional and clinical significance of SALL4 in breast cancer.

Authors:  Ebubekir Dirican; Mustafa Akkiprik
Journal:  Tumour Biol       Date:  2016-07-21

Review 8.  American Registry of Pathology Expert Opinions: Evaluation of poorly differentiated malignant neoplasms on limited samples - Gastrointestinal mucosal biopsies.

Authors:  Andrew M Bellizzi; Elizabeth A Montgomery; Jason L Hornick
Journal:  Ann Diagn Pathol       Date:  2019-11-15       Impact factor: 2.090

9.  The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus.

Authors:  Ergin Kilic; Pierre Tennstedt; Anica Högner; Patrick Lebok; Guido Sauter; Carsten Bokemeyer; Jakob R Izbicki; Waldemar Wilczak
Journal:  Virchows Arch       Date:  2016-01-27       Impact factor: 4.064

Review 10.  The nucleosome remodeling and deacetylase complex in development and disease.

Authors:  Jeannine Basta; Michael Rauchman
Journal:  Transl Res       Date:  2014-05-10       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.